Faced with growing myths and misconceptions surrounding the newly rolled out HIV prevention injection Lenacapavir, the Ministry of Health (MOH) has embarked on a review of its Pre-Exposure Prophylaxis (PrEP) communication strategy to include comprehensive information about the drug.Dr Herb
Kampala, Uganda | URN | The Ministry of Health revealed Friday that demand for Lenacapavir, an HIV prevention injection launched in April, currently surpasses available doses, with more men demanding the twice-yearly drug.Speaking at a meeting attended by HIV advocates, researchers and pol
The Ministry of Health has published Health Centres across the country where Lenacapavir is offered. The List that includes all Regional and General Hospitals also includes some Health Centre III’s.Lenacapavir is a first-in-class, long-acting HIV medication used to treat multi-drug resis
The Uganda Peoples’ Defence Forces (UPDF), through its Health Services, has rolled out lenacapavir, a long-acting injectable Pre-Exposure Prophylaxis (PrEP) drug for HIV prevention which is administered once every six months, in a move aimed at strengthening its HIV response efforts.Spea
Global health is evolving rapidly, with breakthroughs turning into medicine.The latest advancement in viral research is Lenacapavir, an FDA-approved HIV injectable drug manufactured by American biopharmaceutical company Gilead Sciences.Renowned as a convenient, long-acting alternati
Uganda has received its first 19,200 doses of Lenacapavir, a twice-yearly injectable HIV prevention drug supported by the Global Fund and PEPFAR, targeting high-burden districts to curb new infections.Lenacapavir, a twice-yearly HIV prevention injection, is now accessible in Uganda.
Kampala — Uganda has approved Lenacapavir, a twice-yearly injectable HIV prevention medicine developed by Gilead Sciences, in a move health officials say could accelerate the country’s drive to sharply cut new infections and meet global targets to end AIDS as a public health threat by the end
Twenty-five years ago, South Africans battled for ARVs to keep people alive. Now the focus has shifted to medicines that can prevent HIV altogether. Health Beat looks how the story has evolvedSouth Africa has successfully registered twice-a-year anti-HIV jab, lenacapavir.This World
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technologies in the face of waning donor support.Pharmacy and Medicines Regulatory Authority (PMRA) and National Aids Commission
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Healthscientist-hiv-vaccinationA scientist holds a batch of tests. Image: CDC on UnsplashFrom March 2026, people at high risk of contracting HIV will be able to visit
